financetom
Business
financetom
/
Business
/
Novo Nordisk CEO to Testify on High Prices of Ozempic, Wegovy in US Senate Hearing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Novo Nordisk CEO to Testify on High Prices of Ozempic, Wegovy in US Senate Hearing
Jun 17, 2024 4:57 AM

07:41 AM EDT, 06/17/2024 (MT Newswires) -- Novo Nordisk ( NVO ) Chief Executive Lars Jorgensen has agreed to testify voluntarily before the Senate Committee on Health, Education, Labor, and Pensions about the high prices of Ozempic and Wegovy in the US, Sen. Bernie Sanders said Friday.

Sanders, committee chair, said the scheduled subpoena vote will be cancelled and the hearing will be held in September.

The Senate panel is looking into why Americans are paying up to 15 times more for Ozempic and Wegovy than people in other countries, Sanders said.

Price: 141.80, Change: -0.70, Percent Change: -0.49

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved